Seeking AlphaThu, 02 Apr 2026 17:16:11 GMTCogent Biosciences: Blockbuster Potential, Premium Valuation, Still A 'Buy'COGT+2.75%
The Motley FoolSat, 21 Mar 2026 23:13:55 GMTThis $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug LaunchCOGT+2.75%
The Motley FoolSat, 21 Mar 2026 22:23:15 GMTHigh-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest HoldingCOGT+2.75%
The Motley FoolFri, 20 Mar 2026 16:07:58 GMTBiotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026COGT+2.75%
Zacks Investment ResearchTue, 17 Mar 2026 16:40:49 GMTCOGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SMCOGT+2.75%
